Who we are

Who we are

The Association

The Association for Cancer Immunotherapy (CIMT) was founded in 2002 as an information and education platform for the emerging field of immunological cancer therapy. Physicians and researchers from different fields of clinical and theoretical medicine were the founding members of the association that operates as an independent non-profit organization.

The association is financed by donations, congress fees and sponsoring.
CIMT has its offices in Mainz, Germany.

Our Goals

The purpose of CIMT is to promote the development of cancer immunotherapies by:

  • Establishing a communication platform in order to facilitate the communication between scientists of all faculties with interest in cancer immunotherapy. We improve knowledge exchange between industry based scientists, academic scientists, regulatory authorities and physicians alike. Our scientific meetings, educational symposia and publications serve this purpose.
  • Educating health-professionals through annual meetings, advanced education seminars and publication of textbooks.
  • Cooperating with partners in related consortia, regulatory agencies, journals, academic institutions and companies.
  • Initiating working parties that actively accelerate the development in the field.

The Executive Board are:

The Managment Committee are:

The members of the Scientific Advisory Board are:

  • Dr. Philipp Beckhove (Heidelberg)

    DKFZ Heidelberg
    DKFZ-Juniorgruppe T-Zell Tumor Immunität
    Im Neuenheimer Feld 280
    69120 Heidelberg
  • Prof. Dr. Christian Ottensmeier (Southampton)

    Cancer Sciences Division
    Southampton University Hospitals
    Tremona Road
    Southampton SO16 6YD
    United Kingdom
  • Prof. Dr. Giorgio Parmiani (Milan)

    Unit of immune-biotherapy of melanoma and solid tumors
    Fondazione Centro san Raffaele del Monte Tabor
    Building DIBIT
    via Olgettina, 58
    IT-20132 Milano
    ITALY
  • Prof. Dr. Ugur Sahin (Mainz)

    Translational Oncology at University Medical Center Mainz (TRON)
    Langenbeckstraße 1
    55131 Mainz
  • Prof. Dr. Michael Schmitt (Kiel)

    Tumor Immunology Group
    Department of Internal Medicine III
    University of Ulm
    Robert-Koch-Str. 8
    89081 Ulm
  • Dr. Harpreet Singh (Tübingen, Immatics)

    Immatics
    Paul-Ehrlich-Str. 15
    72076 Tübingen
  • Prof. Dr. Freda Stevenson (Southampton)

    Molecular Immunology Group
    Cancer Sciences Division
    School of Medicine, University of Southampton
    MP824, Southampton General Hospital
    Southampton SO16 6YD
    United Kingdom